Clinical Trial Update: Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome. [Phase 3]

View source ↗

Summary

This clinical trial update describes an open-label extension to evaluate the long-term safety of apraglutide in Short Bowel Syndrome (Phase 3). The study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Drugs mentioned

• Apraglutide (apraglutide)

Snippet

Sponsor: VectivBio AG | Conditions: Short Bowel Syndrome | Phase 3 | Status: ACTIVE_NOT_RECRUITING